Oncopharmpod
ASCO '19
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:18:24
- More information
Informações:
Synopsis
Concise reviews of 6 studies from ASCO '19. #Oncopharm agents discussed include olaparib, ribociclib, pembrolizumab, dabrafenib/trametinib, and *losartan. *caveats apply
